-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, Cinda Biotech announced that pemigatinib has been approved by the Food and Drug Administration (TFDA) of the Ministry of Health and Welfare of Taiwan for the treatment of adults who have received systemic drug therapy and tumors with fibroblast growth factor receptor 2 (FGFR2) Locally advanced or metastatic cholangiocarcinoma that is fused or rearranged and cannot be resected